“Herbal Treatment of Headache” by Morris Levin
The article “Herbal Treatment of Headache” by Morris Levin covers the issue of the herbal treatment of headaches. According to the article, herbal therapy has been effective in treating headache disorders for many centuries (Levin, 2012, p. 76). The author analyses botanical therapy and divides it into topical, oral, and aromatherapy categories. However, there is little evidence that supports the effectiveness of herbal treatments. There is a belief that herbal therapies have a potential to help many people suffering from different types of headache. In many countries around the world, people use herbal medicines, and patients are interested in them due to many reasons.
The article analyses oral botanical therapy, which embraces different ways of preparing infusions, teas, capsules, and other medicine. Preparation pitfalls include loss of potency, use of old or improperly prepared ingredients, safety ignorance, and lack of information about the different herbs’ interactions with pharmaceuticals. Further, the article describes topical botanical therapy, which presupposes the use of such agents as menthol, cayenne, peppermint, rosemary, juniper, oils, etc. Aromatherapy is referred to as “the inhalation of the aromas of heated oils for treatment of medical illnesses” (Levin, 2012, p. 79). This therapy involves the use of geranium, rosemary, lavender, sandalwood, and other plants’ oils. Moreover, Levin (2012) mentions homeopathy, which “consists of sublingual use of highly diluted compounds” taken from numerous mineral, botanical, and other sources (p. 79).
The author concludes that the herbal treatment of headaches is effective for many people who suffer from cluster and tension-type headaches as well as migraine. There are different categories of patients that are most suitable for the trials of herbal therapy. They are those who are intolerable to the side effects of other medication, those who want to participate in medical studies, and those who are refractory to pharmaceutical and other therapy modes (Levin, 2012, p. 79). However, lack of funding retards the study process in this area.